Disease Indications: Leukemia, Bile Duct Cancer

Manufacturer: Agios Pharmaceuticals, Inc.

Usage: Oral

Medicine approved by:

Food and Drug Administration (FDA)

Tibsovo (ivosidenib) is designed to treat two conditions: relapsed or refractory acute myeloid leukemia (AML) with an IDH1 mutation, and previously treated, locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with the same mutation.

Disease Indications: Breast Cancer

Manufacturer: Novartis

Usage: Oral

Medicine approved by:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Piqray (alpelisib) is prescribed alongside fulvestrant to treat advanced or metastatic breast cancer in postmenopausal women and men. This combination therapy targets hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer with PIK3CA mutation, identified by an FDA-approved test, after progression on prior endocrine-based treatment.

Disease Indications: Wilson’s disease

Manufacturer: GMP-Orphan (GMPO)

Usage: Intravenous

Medicine approved by:

European Medical Agency (EMA)

Cuprior, manufactured by GMP-Orphan (GMPO), is a vital intravenous medication used to treat Wilson’s disease, a genetic disorder causing excessive copper accumulation in the body.

Disease Indications: Multiple Sclerosis

Manufacturer: Biogen

Usage: Oral

Medicine approved by:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Tecfidera, containing Dimethyl Fumarate, is an oral medication used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It helps reduce the frequency of relapses and delays the progression of disability.

Disease Indications: Amyotrophic Lateral Sclerosis (ALS)

Manufacturer: Bruschettini s.r.l.

Usage: Oral

Medicine approved by:

Italian Medicines Agency (AIFA)

Tudcabil contains Tauroursodeoxycholic Acid (TUDCA), known for its potential neuroprotective properties. It is indicated for patients with Amyotrophic Lateral Sclerosis (ALS) and may help slow disease progression and improve quality of life.

Disease Indications： Lung Cancer, Skin Cancer

Manufacturer： Sanofi

Usage：Intravenous

Medicine approved by：

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Libtayo is a monoclonal antibody that targets the PD-1 pathway, enhancing the immune system’s ability to fight cancer. It is primarily used to treat certain types of lung cancer (non-small cell lung cancer) and skin cancer (cutaneous squamous cell carcinoma and basal cell carcinoma).

Cinnatropin pen containing 30 IU of pharmaceutical-grade human growth hormone, accompanied by 10 disposable needles.

Zptropin is a synthetic human growth hormone used to treat growth hormone deficiency. It is injected subcutaneously using an insulin syringe. The kit of Zptropin contains 10 vials of 16 IU each and comes with bacteriostatic water, totaling 160 IU.